The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Other Stockholders Equity: BDT0.00 Mil (As of . 20)


DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
21 GF Score
Price BDT324.20
View Full Analysis

What is The IBN SINA Pharmaceutical Industry Other Stockholders Equity?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA +1.06% 21 Other Stockholders Equity is BDT0.00 Mil as of . 20. GuruFocus rates DHA:IBNSINA with a GF Score™ of 21/100.

The IBN SINA Pharmaceutical Industry's Other Stockholders Equity for the quarter that ended in . 20 was BDT0.00 Mil.

The IBN SINA Pharmaceutical Industry Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry Other Stockholders Equity Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Other Stockholders Equity

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Other Stockholders Equity
DHA:IBNSINA
21GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of BDT0.00 Mil mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a Other Stockholders Equity of BDT0.00 Mil as of . 20. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on The IBN SINA Pharmaceutical Industry and its competitors.
Is The IBN SINA Pharmaceutical Industry's Other Stockholders Equity too high?
The IBN SINA Pharmaceutical Industry's current Other Stockholders Equity is BDT0.00 Mil. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's Other Stockholders Equity compare to IMNPQ?
The IBN SINA Pharmaceutical Industry's Other Stockholders Equity of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. The IBN SINA Pharmaceutical Industry's current Other Stockholders Equity is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current Other Stockholders Equity of BDT0.00 Mil. The current Other Stockholders Equity is BDT0.00 Mil. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current Other Stockholders Equity is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
21GF Score

Get the complete analysis for DHA:IBNSINA

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT324.20
Price